Caspian Journal of Internal Medicine
Babol University of Medical Sciences
Sat, Jun 7, 2025
[Archive]
Volume 16, Issue 3 (Summer 2025)
Caspian J Intern Med 2025, 16(3): 417-423 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Asgarirad H, Mahjoub S, yadollahi M, Navaee S, Amirkhanloo S, shohreh A. The effectiveness of sumac seeds (Rhus coriaria L.) capsules prepared from an aqueous extract in diabetic patients: A double-blind clinical trial study. Caspian J Intern Med 2025; 16 (3) :417-423
URL: http://caspjim.com/article-1-4237-en.html
URL: http://caspjim.com/article-1-4237-en.html
Hossein Asgarirad 
, Soleiman Mahjoub , Mohsen Yadollahi * , Siamak Navaee , Shervin Amirkhanloo , AliSina Shohreh
, Soleiman Mahjoub , Mohsen Yadollahi * , Siamak Navaee , Shervin Amirkhanloo , AliSina Shohreh
Department of Food Hygiene and Quality Control, Faculty of Health, Mazandaran University of Medical Sciences, Sari, Iran. , mohsen.21501@yahoo.com
Abstract: (128 Views)
Background: Type 2 diabetes or non-insulin-dependent diabetes is one of the most common types of diabetes. The existing treatments for type 2 diabetes have not been able to completely cure this disease in affected cases. Sumac showed antioxidants, reducing blood sugar and serum cholesterol levels. In this study, according to the positive effects of sumac in diabetic diseases, it was tried that sumac capsules were prepared from the aqueous extract of this plant, and its effect on the factors of diabetes in patients was evaluated.
Methods: This double-blind randomized controlled clinical trial was conducted on sixty type 2diabetic volunteers. The volunteers were divided into two groups, control, and sumac supplement groups. Baseline venous blood samples were collected after overnight fasting before intervention and a second sampling was done in the 12th week. Hb1AC, FBS, TG, TC, LDL-C, and HDL-C were measured via commercial kits.
Results: FBS, HDL-C, and HbA1C measured in the sumac supplement group were significantly different (p<0.01) compared to the control group and baseline of the study. Moreover, there is no significant difference in levels of the sumac supplement group (CHOL, LDL-C, and TG) compared to the control group and baseline of the study (p>0.05).
Conclusion: Our data confirmed the anti-diabetic effect of sumac in patients. Because of sumac safety, it seems that sumac capsules can be used for the treatment of diabetic patients along with routine chemical drugs
Methods: This double-blind randomized controlled clinical trial was conducted on sixty type 2diabetic volunteers. The volunteers were divided into two groups, control, and sumac supplement groups. Baseline venous blood samples were collected after overnight fasting before intervention and a second sampling was done in the 12th week. Hb1AC, FBS, TG, TC, LDL-C, and HDL-C were measured via commercial kits.
Results: FBS, HDL-C, and HbA1C measured in the sumac supplement group were significantly different (p<0.01) compared to the control group and baseline of the study. Moreover, there is no significant difference in levels of the sumac supplement group (CHOL, LDL-C, and TG) compared to the control group and baseline of the study (p>0.05).
Conclusion: Our data confirmed the anti-diabetic effect of sumac in patients. Because of sumac safety, it seems that sumac capsules can be used for the treatment of diabetic patients along with routine chemical drugs
Type of Study: Original Article |
Subject:
pharmacology
Received: 2024/01/8 | Accepted: 2024/05/12 | Published: 2025/06/10
Received: 2024/01/8 | Accepted: 2024/05/12 | Published: 2025/06/10
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
